title: [Nicotine substitution therapy: 10 years later].
abstract: To be efficient, nicotine substitution therapy (NST) must be part of a global strategy comprising several stages. The first consists in evaluating and re-enforcing motivation, since smoking cessation is impossible unless the patient is clearly motivated. The second stage is the withdrawal period that lasts for several days or months. NST is the first medicinal treatment that has demonstrated its efficacy in controlled studies: it reduces the withdrawal syndrome and doubles the chances of success at the end of the standard 3-month treatment. Recent studies have shown that the results can be improved: by adapting the dose to the degree of dependency and by using higher doses and/or associating two types of nicotine substitutes; by prolonging NST for as long as the withdrawal syndrome persists; by treating the anxiety and depression, often present in heavy smokers. The third stage is aimed at avoiding relapses, by ensuring prolonged follow-up and treating the various possible causes: eating disorders and weight gain, acute or chronic stress, depression, environment.... At all the stages of care, behavioural and cognitive therapy enhances the chances of success.
authors.affiliation: Centre de Tabacologie, Hôpital Albert Chenevier, 40 rue de Mesly F94000 Créteil. gilbert.lagrue@ach.ap-hop-paris.fr
authors.forename: G
authors.initials: G
authors.lastname: Lagrue
authors.forename: P
authors.initials: P
authors.lastname: Dupont
authors.forename: R
authors.initials: R
authors.lastname: Fakhfakh
authors.forename: C
authors.initials: C
authors.lastname: Mautrait
authors.forename: S
authors.initials: S
authors.lastname: Lormier
mesh_terms: D000279:Administration, Cutaneous; D002638:Chewing Gum; D002986:Clinical Trials as Topic; D018849:Controlled Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D009042:Motivation; D009538:Nicotine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D010919:Placebos; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D061485:Tobacco Use Cessation Devices
chemical_list: D002638:Chewing Gum; D010919:Placebos; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine